# Baclofen to Reduce Alcohol Use in Veterans With HCV

> **NCT01008280** · PHASE4 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 180 (actual)

## Conditions studied

- Hepatitis C
- Alcohol Use Disorders

## Interventions

- **DRUG:** baclofen
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01008280
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2014-03
- **Final completion:** 2015-09
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01008280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01008280, "Baclofen to Reduce Alcohol Use in Veterans With HCV". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01008280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*